Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways (Resistance to Targeted Anti-Cancer Therapeutics, Band 15)

Wo zu kaufen (1) Eigenschaften

Gesponsert

Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways (Resistance to Targeted Anti-Cancer Therapeutics, Band 15)

Medimops DE

154.34 EUR

Preis aktualisiert am: 16-09-2026 07:37:30

Siehe Produktangebot

Allgemein

Marke

Springer

Eigenschaften

Ähnliche Produkte

Resistance to Targeted Therapies Against Adult Brain Cancers (Resistance to Targeted Anti-Cancer Therapeutics)

Resistance to Targeted Therapies Against Adult Brain Cancers (Resistance to Targeted Anti-Cancer Therapeutics)

Produkt anzeigen

Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy (Resistance to Targeted Anti-Cancer Therapeutics)

Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy (Resistance to Targeted Anti-Cancer Therapeutics)

Produkt anzeigen

Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways (Resistance to Targeted Anti-Cancer Therapeutics)

Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways (Resistance to Targeted Anti-Cancer Therapeutics)

Produkt anzeigen

Resistance to Targeted Therapies in Breast Cancer (Resistance to Targeted Anti-Cancer Therapeutics)

Resistance to Targeted Therapies in Breast Cancer (Resistance to Targeted Anti-Cancer Therapeutics)

Produkt anzeigen

Resistance to Aromatase Inhibitors in Breast Cancer (Resistance to Targeted Anti-Cancer Therapeutics)

Resistance to Aromatase Inhibitors in Breast Cancer (Resistance to Targeted Anti-Cancer Therapeutics)

Produkt anzeigen

TRAIL, Fas Ligand, TNF and TLR3 in Cancer (Resistance to Targeted Anti-Cancer Therapeutics, Band 12)

TRAIL, Fas Ligand, TNF and TLR3 in Cancer (Resistance to Targeted Anti-Cancer Therapeutics, Band 12)

Produkt anzeigen